117528-59-3 Usage
Description
3-CYANO-2,4-DICHLORO-5-FLUOROBENZOYLCHLORIDE is an organic compound characterized by its unique molecular structure, featuring a benzoyl chloride backbone with a cyano group, two chlorine atoms, and a fluorine atom. 3-CYANO-2,4-DICHLORO-5-FLUOROBENZOYLCHLORIDE is known for its reactivity and potential applications in the synthesis of various pharmaceuticals and chemical products.
Uses
Used in Pharmaceutical Industry:
3-CYANO-2,4-DICHLORO-5-FLUOROBENZOYLCHLORIDE is used as a reactant in the preparation of cyano(cyclopropyl)quinolonecarboxylates, which are employed as antibacterial agents. Its unique structure allows for the development of new and effective treatments against bacterial infections, contributing to the advancement of medicine and healthcare.
Check Digit Verification of cas no
The CAS Registry Mumber 117528-59-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,5,2 and 8 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 117528-59:
(8*1)+(7*1)+(6*7)+(5*5)+(4*2)+(3*8)+(2*5)+(1*9)=133
133 % 10 = 3
So 117528-59-3 is a valid CAS Registry Number.
117528-59-3Relevant articles and documents
A novel approach to Finafloxacin hydrochloride (BAY35-3377)
Hong, Jian,Zhang, Zonghua,Lei, Huoxing,Cheng, Haiying,Hu, Yufang,Yang, Wanliang,Liang, Yinglin,Das, Debasis,Chen, Shu-Hui,Li, Ge
experimental part, p. 2525 - 2528 (2009/09/06)
Finafloxacin hydrochloride, an important clinical compound was synthesized by a novel synthetic approach. An active intermediate ethyl 7-chloro-8-cyano-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate 19 was prepared by a new route. The chiral (S,S′)-N-Boc 10 was derived from protected pyrrolidine and the absolute stereochemistry was established by X-ray analysis.
Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith
-
, (2008/06/13)
The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in position 7 by a 1-aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl radical, and of their salts for the therapy ofHelicobacter pyloriinfections and associated gastroduodenal disorders.
